Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
University of Vienna · Centre international de recherche sur le cancer · +31 more institutions
Abstract
It is currently unknown whether ultra-processed foods (UPFs) consumption is associated with a higher incidence of multimorbidity. We examined the relationship of total and subgroup consumption of UPFs with the risk of multimorbidity defined as the co-occurrence of at least two chronic diseases in an individual among first cancer at any site, cardiovascular disease, and type 2 diabetes.
This was a prospective cohort study including 266,666 participants (60% women) free of cancer, cardiovascular disease, and type 2 diabetes at recruitment from seven European countries in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Foods and drinks consumed over the previous 12 months were assessed at baseline by food-frequency questionnaires and classified according to their degree of processing using Nova classification. We used multistate modelling based on Cox regression to estimate cause-specific hazard ratios (HR) and their 95% confidence intervals (CI) for associations of total and subgroups of UPFs with the risk of multimorbidity of cancer and cardiometabolic diseases.
Citation impact
- FWCI
- 56.45
- Percentile
- 100%
- References
- 51
Authors
35- RCReynalda CórdovaCorresponding
University of Vienna, Centre international de recherche sur le cancer
- VVVivian Viallon
Centre international de recherche sur le cancer
- EFEmma Fontvieille
Centre international de recherche sur le cancer
- LPLaia Peruchet‐Noray
Centre international de recherche sur le cancer
- AJAnna Jansana
Centre international de recherche sur le cancer
Topics & keywords
- Multinational corporation
- Environmental health
- Multimorbidity
- Medicine
- Cohort
- Cancer
- Cohort study
- Consumption (sociology)
Funding
- WHWorld Health Organization
- KBKræftens Bekæmpelse
- DKDeutsches KrebsforschungszentrumAwards: 14136, MR/M012190/1, 1000143
- CICentre International de Recherche sur le Cancer
- HRHealth Research Foundation
- NRNational Research Council
- WCWorld Cancer Research Fund InternationalAward: IIG_FULL_2020_033
- CRCancer Research UKAwards: C33493/A29678, A29017, 14136, 1000143, C8221/A29017, MR/M012190/1
- NINational Institute for Health and Care ResearchAwards: 14136, 1000143, MR/M012190/1
- ICImperial College London
- INInstitut National de la Santé et de la Recherche MédicaleAwards: MR/M012190/1, 1000143, 14136
- ÖAÖsterreichischen Akademie der Wissenschaften
- BFBundesministerium für Bildung und ForschungAwards: 1000143, 14136, MR/M012190/1
- CCancerfondenAward: 14136
- MVMinisterie van Volksgezondheid, Welzijn en Sport
- LCLigue Contre le CancerAwards: MR/M012190/1, 14136, 1000143
- VVetenskapsrådetAwards: 14136, 1000143, MR/M012190/1
- FDFondation de FranceAwards: 00081166, MR/M012190/1, 14136, 1000143
- AIAssociazione Italiana per la Ricerca sul CancroAwards: 1000143, MR/M012190/1, 14136
- DKDeutsche KrebshilfeAwards: 14136, MR/M012190/1, 1000143
- INInstitut National Du CancerAwards: 2021-138, 1000143, MR/M012190/1, 14136
- IGInstitut Gustave-RoussyAwards: MR/M012190/1, 14136, 1000143
- MGMutuelle Générale de l'Education NationaleAwards: MR/M012190/1, 14136, 1000143
- CDConsejería de Salud y Familias, Junta de Andalucía
- UOUniversity of Maryland School of Public Health
- MRMedical Research CouncilAwards: M012190/1, 14136, MR/M012190, 1000143, MR/M012190/1
- WCWorld Cancer Research FundAwards: 14136, MR/M012190/1, 1000143, IIG_FULL_2020_033
- IDInstituto de Salud Carlos III
- RVRijksinstituut voor Volksgezondheid en MilieuAward: 00081166
- NINIHR Imperial Biomedical Research Centre
- SOSchool of Public Health, Imperial College London
- DODepartment of Epidemiology and Biostatistics, University of California, San Francisco